Rocket Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 02/17/2026 | 17.69 M | $62.08 M | 0.00% | 15.85% |
| VANGUARD GROUP INC | 01/29/2026 | 8.54 M | $29.99 M | 23.97% | 7.66% |
| BLACKROCK, INC. | 02/12/2026 | 7.91 M | $27.75 M | 11.13% | 7.09% |
| CITIGROUP INC | 02/13/2026 | 5.25 M | $18.41 M | 50,224.69% | 4.70% |
| MORGAN STANLEY | 02/13/2026 | 3.94 M | $13.83 M | 8.07% | 3.53% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 2.99 M | $10.50 M | -22.13% | 2.68% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2026 | 2.99 M | $10.49 M | 3.29% | 2.68% |
| NEWTYN MANAGEMENT, LLC | 02/17/2026 | 2.65 M | $9.30 M | 5.88% | 2.38% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 2.64 M | $9.27 M | 20.59% | 2.37% |
| MAVERICK CAPITAL LTD | 02/13/2026 | 2.51 M | $8.82 M | -70.32% | 2.25% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 2.13 M | $7.48 M | 32.44% | 1.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.12 M | $7.44 M | 10.74% | 1.90% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.86 M | $6.54 M | 3.84% | 1.67% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.78 M | $6.27 M | -50.01% | 1.60% |
| STATE STREET CORP | 02/13/2026 | 1.70 M | $5.97 M | -2.56% | 1.52% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.59 M | $5.57 M | -59.37% | 1.42% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.48 M | $5.18 M | -29.63% | 1.32% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.30 M | $4.56 M | -22.20% | 1.17% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 955.00 K | $3.35 M | 100.00% | 0.86% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 944.87 K | $3.32 M | -10.97% | 0.85% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 936.59 K | $3.29 M | -26.32% | 0.84% |
| FEDERATED HERMES, INC. | 02/12/2026 | 881.25 K | $3.09 M | 40.42% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 744.29 K | $2.61 M | 0.03% | 0.67% |
| PROSIGHT MANAGEMENT, LP | 02/13/2026 | 743.94 K | $2.61 M | -41.33% | 0.67% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 703.53 K | $2.47 M | -19.44% | 0.63% |
| NORTHERN TRUST CORP | 02/17/2026 | 618.65 K | $2.17 M | -5.84% | 0.55% |
| JANE STREET GROUP, LLC | 02/12/2026 | 602.58 K | $2.12 M | 24.38% | 0.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 579.51 K | $2.03 M | 12.54% | 0.52% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 507.91 K | $1.78 M | 100.00% | 0.46% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 499.33 K | $1.75 M | -20.18% | 0.45% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 475.80 K | $1.67 M | -17.37% | 0.43% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 474.87 K | $1.67 M | 488.18% | 0.43% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 434.41 K | $1.52 M | 0.00% | 0.39% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 421.17 K | $1.48 M | 207.03% | 0.38% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 400.71 K | $1.41 M | -69.50% | 0.36% |
| FMR LLC | 02/17/2026 | 395.28 K | $1.39 M | 26.81% | 0.35% |
| M28 CAPITAL MANAGEMENT LP | 02/13/2026 | 385.68 K | $1.35 M | 0.00% | 0.35% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 348.80 K | $1.22 M | 100.00% | 0.31% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 338.83 K | $1.19 M | -39.04% | 0.30% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/14/2026 | 309.25 K | $1.09 M | 1.25% | 0.28% |
| INVESCO LTD. | 02/19/2026 | 304.44 K | $1.07 M | 36.85% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 250.96 K | $880.88 K | 2.30% | 0.22% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 242.17 K | $847.00 K | 15.40% | 0.22% |
| PDT PARTNERS, LLC | 02/17/2026 | 220.88 K | $775.30 K | -16.96% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 219.97 K | $772.11 K | -78.31% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 193.43 K | $678.94 K | 121.47% | 0.17% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 187.40 K | $693.38 K | -29.13% | 0.17% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 178.93 K | $628.03 K | -26.12% | 0.16% |
| AMITELL CAPITAL PTE LTD | 02/12/2026 | 178.77 K | $627.48 K | 0.00% | 0.16% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 170.15 K | $597.21 K | -60.68% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rocket Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 257 institutional investors and hedge funds held shares of Rocket Pharmaceuticals Inc. The most heavily invested institutionals were:
Nuveen, LLC: 3.13 M
UBS Group AG: 1.3 M
abrdn plc: 664,821
Privium Fund Management B.V.: 242,146
Bank of New York Mellon Corp: 239,842
Assenagon Asset Management S.A.: 99,026
81.80% of Rocket Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 243.92 M shares in the last 24 months. This purchase volume represents approximately $1.25 B in transactions.